Rashtriya Newsflash

Global Mobile ECG Devices Market Set for Rapid Expansion at 11.7% CAGR by 2032 | AliveCor, Beurer UK Ltd., Omron

 Breaking News
  • No posts were found

Global Mobile ECG Devices Market Set for Rapid Expansion at 11.7% CAGR by 2032 | AliveCor, Beurer UK Ltd., Omron

July 15
17:25 2025
Global Mobile ECG Devices Market Set for Rapid Expansion at 11.7% CAGR by 2032 | AliveCor, Beurer UK Ltd., Omron

Mobile ECG devices are compact, portable monitors for detecting heartbeat irregularities. Patch-based versions use a small adhesive patch placed on the chest, equipped with electrodes that record continuous electrical signals for up to weeks. They transmit data wirelessly—typically via Bluetooth—to a smartphone, offering discreet, lead-free monitoring. The downside is their limited battery and adhesive duration.

Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/6551

Global Mobile ECG Devices Market Key Takeaways

According to Coherent Market Insights (CMI), the global mobile ECG devices market size is expected to reach USD 6.717.4 Mn by 2032, up from USD 3,096.2 Mn in 2025.

Global demand for mobile ECG devices is poised to increase at a CAGR of 11.7% between 2025 and 2032.

Based on modality, pen category segment is set to account for more than two-fifths of the global mobile ECG devices market share in 2025.

North America is likely to maintain its market dominance, holding a prominent industry share of 37.2% in 2025.

Asia Pacific is projected to remain the second-leading market for mobile ECG devices, accounting for nearly one-fourth of the global market share in 2025.

As per CMI’s new global mobile ECG devices market analysis, Europe is poised to experience fastest growth during the assessment period.

Rising Cardiovascular Disease Burden Spurring Market Growth

Coherent Market Insights’ latest global mobile ECG devices market research offers insights into key factors driving industry growth. Increasing prevalence of cardiovascular diseases (CVDs) is one such prominent growth driver.

Conditions like heart attacks, arrhythmias, ischemic heart disease, and atrial fibrillation are on the rise. According to a study published in the Journals of the American College of Cardiology (JACC), cardiovascular mortality rates are projected to increase by 50.2% between 2025 and 2050.

The growing CVD burden is expected to drive demand for mobile ECG devices. This is because many of these conditions require continuous or real-time cardiac monitoring.

Mobile ECG devices, also referred to as portable ECG monitors, enable real-time, remote monitoring in both clinical and homecare settings. These devices are increasingly valued for their role in the early detection and management of cardiac conditions.

Buy the Complete Report with an Impressive Discount (Up to 25% Off) at:https://www.coherentmarketinsights.com/insight/buy-now/6551

Regulatory Hurdles and High Cost Restraining Market Growth

The global mobile ECG devices market outlook indicates robust future growth. However, strict regulatory requirements and high cost of advanced mobile ECG devices are expected to restrain market growth to some extent.

Medical devices like mobile ECG systems undergo stringent approval processes. These regulatory complexities often delay time-to-market, thereby negatively impacting the global mobile ECG devices market growth.

Many advanced mobile ECG systems are expensive. This cost barrier deters their adoption, especially across low- and middle-income nations, reducing overall global mobile ECG devices market demand.

Rising Need for Remote Patient Monitoring (RPM) Creating Growth Opportunities

Adoption of telemedicine and home-based care is rising significantly due to advancements in digital health technologies and growing need for accessible, cost-effective healthcare. This trend is driving increased use of mobile ECG devices, which offer convenient and continuous cardiac monitoring.

Mobile ECG devices support remote patient monitoring by transmitting real-time data to healthcare professionals for timely intervention. Thus, growing demand for remote patient monitoring is expected to create a plethora of opportunities for mobile ECG device companies.

Impact of AI on the Global Mobile ECG Devices Market

Artificial intelligence (AI) is becoming a powerful tool in the mobile ECG devices market. This advanced technology is improving diagnostic accuracy, enabling early detection of cardiac conditions, and contributing to overall market expansion.

AI-powered algorithms now interpret real-time ECG data to detect arrhythmias more accurately than traditional systems. By doing so, they significantly reduce false positives and enable earlier clinical interventions.

Companies like AliveCor and iRhythm Technologies Inc. are leading from the forefront when it comes to AI adoption. For instance, AliveCor’s FDA-cleared Kardia 12L employs AI to recognize 35 different cardiac conditions.

Similarly, in May 2025, iRhythm Technologies advanced AI-powered arrhythmia detection with the launch of Zio EXG Recording and Analysis System in Japan. This novel system provides up to 14 days of continuous, uninterrupted ECG monitoring and uses a deep-learned AI algorithm approved by Japan’s PMDA.

Emerging Global Mobile ECG Devices Market Trends

Growing preventive healthcare trends are playing a key role in boosting sales of mobile ECG devices. Modern consumers are increasingly adopting self-monitoring devices like mobile ECG due to heightened awareness of heart health and preventive care.

Rising geriatric population is expected to positively influence the global mobile ECG devices market value during the forecast period. Older individuals are more prone to heart conditions that require consistent ECG monitoring.

Another key growth-shaping trend in the mobile ECG devices market is the technological advancements in wearable ECG devices. Integration of mobile ECG devices with smartphones, AI, and cloud computing is enhancing their accuracy and usability. These innovations are expected to expand their applications, thereby fostering market growth.

Request Customization: https://www.coherentmarketinsights.com/insight/request-customization/6551

Analyst’s View

“The global mobile ECG devices industry is slated for rapid expansion, owing to rising prevalence of cardiovascular diseases, growing demand for remote monitoring devices, favorable government initiatives, and advancements in portable ECG technologies,” said senior analyst Manisha Vibhute.

Current Events and Their Impact on the Global Mobile ECG Devices Market

Event

Description and Impact

Rise of Wearable Ecosystem Partnerships (2024–2025)

  • Description: Major tech firms (Apple, Samsung, Fitbit) are expanding into clinical-grade ECG monitoring via partnerships with healthcare systems and AI startups.
  • Impact: These collaborations are enhancing the credibility and functionality of mobile ECGs, driving broader consumer and clinical adoption

Reimbursement Code Expansions in the U.S. and EU

  • Description: CMS in the United States introduced specific reimbursement codes for remote cardiac monitoring using mHealth solutions.
  • Impact: Financial support from public and private payers is encouraging healthcare providers to incorporate mobile ECGs into routine care.

AI/ML Approval Acceleration by Regulatory Bodies

  • Description: The FDA and EMA have fast-tracked AI-driven diagnostic tools under new guidelines (e.g., FDA’s Predetermined Change Control Plan updates in 2024).
  • Impact: These regulatory shifts are facilitating faster market entry of AI-enabled mobile ECGs, such as AliveCor’s Kardia AI V3 and other next-gen platforms.

Competitor Insights

Key companies listed in the global mobile ECG devices market report include:

– Beurer UK Ltd.

– AliveCor

– GE Healthcare

– Borsam Biomedical Instrument

– Medtronic

– Koninklijke Philips N.V.

– iRhythm Technologies, Inc.

– Dr Trust

– Emay

– Nihon Kohden Corporation

– Omron

– Lepu Medical Technology(Beijing) Co. Ltd.

– Panasonic Industry

– InfoBionic

– BHA MEDICAL

Key Developments

In May 2025, iRhythm Technologies Inc. launched the new Zio EXG Recording and Analysis System in Japan. This new system provides up to 14 days of continuous, uninterrupted cardic monitoring. It consists of a prescription-only, patch-based ECG monitoring device worn for up to 14 days.

In May 2024, Omron Healthcare India collaborated with AliveCor to introduce AI-powered portable ECG monitoring devices in India. The initiative aimed to boost cardiovascular health management by providing handheld, AI-enhanced ECG technology.

In June 2024, AliveCor announced U.S. FDA clearance as well as commercial launch of the Kardia 12L ECG system. This is the world’s first AI system capable of detecting life-threatening cardiac conditions using a reduced leadset.

Detailed Segmentation:

Global Mobile ECG devices Market, By Modality

Pen

Band

Handheld

Others

Global Mobile ECG devices Market, By End User

Hospitals

Diagnostic Centers

Ambulatory Care

Homecare

Others

Global Mobile ECG devices Market, By Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Shah
Email: Send Email
Phone: + 12524771362
Address:533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Country: United States
Website: https://www.coherentmarketinsights.com/industry-reports/global-mobile-ecg-devices-market